Prenatal Exposure to DES Linked to Breast Cancer

Pharmaceutical Lawsuit and Recall Information

After the drug diethylstilbestrol (DES) was taken off the market, several studies revealed that the medication could potentially cause reproductive tract defects and cancers in girls born to mothers who took the drug during pregnancy. Recently, a group of breast cancer patients have filed suit in a Boston court, claiming their cancers were caused by [...]

Atypical Antipsychotics Potentially Harmful for Elderly Patients


Based on the review of new meta-analysis, the off-label use of atypical antipsychotics in elderly patients could potentially do more harm than good. The study, the largest of its kind on the subject, could prompt clinicians to potentially reconsider the way they prescribe these drugs. Approved by the U.S. Food and Drug Administration for the [...]

Drospirenone-Containing Birth Control Pills Still Under Scrutiny

Yaz Lawyer

In a new drug safety communication posted today on the U.S. Food and Drug Administration’s website, the agency announced that preliminary results of a study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. Popular [...]

VA Stops Use of Avastin for Eye Infections

Breast Cancer Drug FDA Preview

The U.S. Department of Veterans Affairs this week announced that it has discontinued its use of Roche’s popular drug, Avastin, as a treatment for eye disease, pending the results of an investigation into the safety and efficacy of the drug when used for ophthalmologic purposes. The VA’s decision to drop the drug was ultimately based [...]

J&J Resumes Shipment of Tylenol Cold & Flu Caplets

Johnson and Johnson

Johnson & Johnson’s McNeil Consumer Healthcare division has announced that it has officially resumed the shipment of Tylenol Cold & Flu Severe caplets, a product which had previously been recalled due to manufacturing deficiencies. In a timely and smart move, the company positioned its resumption of shipping activities to coincide with the upcoming cold and [...]

FDA Stops Sale of Supplements Marketed Under False Drug Claims

FDA Drug Recalls/ Rxrecall/ The Maher Law Firm

This week, the FDA filed a permanent injunction against two Minnesota companies that marketed and sold amino acid supplements as treatments for Parkinson’s, Alzheimer’s and other neurological disorders. To make matters worse, the companies also marketed their “amino-acid therapy” products as treatments for other problems, such as depression, attention-deficit hyperactivity disorder, fibromyalgia and obsessive compulsive [...]

FDA Briefs Congress on Safety Concerns of Imported Drugs


While the FDA has made forward progress regarding the inspection of drugs manufactured overseas, the issue of deadly drug contamination caused by foreign producers continues to be a growing problem. Currently, the FDA is not able to fully guarantee the safety of drug products made overseas, nor are they able to adequately monitor the safety [...]

New Recall Alert for Oral Contraceptives

birth control pills / The Maher Law Firm

Qualitest Pharmaceuticals has issued a nationwide, retail-level recall of several lots of its birth control pills, following a packaging error that could lead to improper dosing, leaving women without proper protection and increasing their risk for unintended pregnancy. The U.S. Food and Drug Administration has instructed consumers who have already been exposed to the affected [...]

Glaxo’s Zofran May Trigger Serious Heart Arrhythmias

Zofran Lawyer

According to a new warning issued last week by the U.S. Food and Drug Administration, GlaxoSmithKline’s popular drug, Zofran, which is used to treat nausea caused by chemotherapy, has been reported to trigger serious and potentially life-threatening changes in heart rhythms. In its warning, the FDA explained that Zofran, otherwise known as ondansetron, can increase [...]

J&J Unit Pays $85 Million Fine Over Misbranding

Pharamaceutical Lawsuit and Recall Information

Pharmaceutical powerhouse, Johnson & Johnson, has recently been the subject of several legal problems regarding the marketing practices for some of their most popular medications. The latest development involves the company’s Scios unit agreeing to pay an $85 million fine and plead guilty to misbranding the heart drug, Natrecor. In July, prosecutors charged Scios with [...]